Press releaseGlobe Newswire
Aktis Oncology
AKTS · NASDAQ
$16.08+$0.97 (+6.42%)TodayMarket closed ·
Prev close $15.11
Latest news
- NewsPiero Cingari
Micron and 15 Other Stocks To Play The AI Buildout Race: They Are Still 20% Below Highs
- Press releaseGlobe Newswire
Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026
- Press releaseGlobe Newswire
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
- Press releaseGlobe Newswire
Aktis Oncology Reports Financial Results and Business Highlights for First Quarter 2026
- Press releaseGlobe Newswire
Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Press releaseBusiness Wire
Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics' Acquisition by UCB
- Press releaseGlobe Newswire
Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
- Press releaseGlobe Newswire
Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors
- Press releaseGlobe Newswire
Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results
- Press releaseGlobe Newswire
Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate
- Press releaseBusiness Wire
Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets
- News
12 Information Technology Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Down 1%; Webuy Global Shares Spike Higher
- NewsAvi Kapoor
Nasdaq Surges Over 100 Points; NY Empire State Manufacturing Index Dips In December
- NewsAvi Kapoor
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
- Press releaseBusiness Wire
Akoustis to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
- News
12 Information Technology Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- News
12 Information Technology Stocks Moving In Friday's Pre-Market Session
- News
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
- News
12 Information Technology Stocks Moving In Monday's After-Market Session
- News
12 Information Technology Stocks Moving In Tuesday's Intraday Session
- News
12 Information Technology Stocks Moving In Thursday's Intraday Session
- NewsAvi Kapoor
Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
- NewsErica Kollmann
Why Akoustis Technologies Stock Is Up Today
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.